2017
DOI: 10.3389/fphys.2017.00818
|View full text |Cite
|
Sign up to set email alerts
|

Low-Intensity Ultrasound-Induced Anti-inflammatory Effects Are Mediated by Several New Mechanisms Including Gene Induction, Immunosuppressor Cell Promotion, and Enhancement of Exosome Biogenesis and Docking

Abstract: Background: Low-intensity ultrasound (LIUS) was shown to be beneficial in mitigating inflammation and facilitating tissue repair in various pathologies. Determination of the molecular mechanisms underlying the anti-inflammatory effects of LIUS allows to optimize this technique as a therapy for the treatment of malignancies and aseptic inflammatory disorders.Methods: We conducted cutting-edge database mining approaches to determine the anti-inflammatory mechanisms exerted by LIUS.Results: Our data revealed foll… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
87
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 68 publications
(96 citation statements)
references
References 112 publications
9
87
0
Order By: Relevance
“…Cancer cells actively release EVs into the surrounding microenvironment and these vesicles have been reported to play multiple functions in the regulation of tumor growth and progression. Since Rac1 is involved in EVs biogenesis (Yang et al, 2017) and we found that Rac1 was affected by LIPUS treatment (Figure 7), we also aimed at analyzing whether LIPUS might affect cellular release and/or uptake of EVs. We aimed to quantify this increase and we used a flow cytometry‐based method that we have set up for the evaluation of EVs directly in supernatant of cancer cells and, as shown in Figure 8, we found that LIPUS treatment increased the release of EVs up to 20% and 10% in Caco2 and HT29 cells, respectively (Figure 8a,b).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Cancer cells actively release EVs into the surrounding microenvironment and these vesicles have been reported to play multiple functions in the regulation of tumor growth and progression. Since Rac1 is involved in EVs biogenesis (Yang et al, 2017) and we found that Rac1 was affected by LIPUS treatment (Figure 7), we also aimed at analyzing whether LIPUS might affect cellular release and/or uptake of EVs. We aimed to quantify this increase and we used a flow cytometry‐based method that we have set up for the evaluation of EVs directly in supernatant of cancer cells and, as shown in Figure 8, we found that LIPUS treatment increased the release of EVs up to 20% and 10% in Caco2 and HT29 cells, respectively (Figure 8a,b).…”
Section: Resultsmentioning
confidence: 99%
“…Our study confirmed the involvement of Rho GTPase in cell motility induced by LIPUS. Moreover, analyzing the gene expression profiles of microarray datasets on US‐treated cells, Yang et al (2017) showed that LIPUS enhanced EVs biogenesis and internalization. D'Souza et al also showed that US can be used to amplify and localize biomarkers in blood with a relatively simple and noninvasive strategy (D'Souza et al, 2009; Paproski, Jovel, Wong, Lewis, & Zemp, 2017).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These mechanisms include LIPUS inhibiting expression of inflammatory factors like IL‐1α, upregulating expression of anti‐inflammatory genes 25 and reducing infiltration of inflammatory cells into the synovium . It was reported recently that LIPUS enhanced DC‐derived exosome biogenesis and docking . Exosome‐carried anti‐inflammatory cytokines and anti‐inflammatory miRNAs are able to inhibit inflammation of target cells .…”
mentioning
confidence: 99%
“…Low-frequency US combined with microbubbles simultaneously promotes dendritic cells (DCs) to differentiate and mature in the cancer microenvironment 45. In addition, this phenomenon promotes T lymphocytes to trigger antitumor immunity mediated by T lymphocytes, which enhance the efficacy of angiogenesis targeting 46.…”
Section: Immunotherapy Assisted By Ummdmentioning
confidence: 99%